Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesMen Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras
The Journal of Urology, 10/21/09
Sun L et al. – Men older than 70 years had higher risk disease and poorer survival in the early and late prostate specific antigen eras. Pathological Gleason sums did not change between the 2 eras. Patient age was an important variable in prostate specific antigen screening, biopsy, treatment and prognosis.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/19/10
Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets
Laboratory Investigation, 03/19/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intrathecal Catheter-Syringe Adaptor for Short-Term Intrathecal Analgesia with an Externalized Pump: A Case Report
Pain Physician, 03/19/10
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Polycythemia vera
Internal and Emergency Medicine, 03/19/10
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intrathecal Catheter-Syringe Adaptor for Short-Term Intrathecal Analgesia with an Externalized Pump: A Case Report
Pain Physician, 03/19/10
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Polycythemia vera
Internal and Emergency Medicine, 03/19/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
The importance of patient selection in the treatment of distal hypospadias using modified Koff procedure
Journal of Pediatric Urology , 03/19/10
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Screening for kidney disease on World Kidney Day in Jalisco, Mexico
Journal of Nephrology, 03/19/10
Are oral antibiotics equivalent to intravenous antibiotics for the initial management of pyelonephritis in children?
Paediatrics & Child Health, 03/19/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intrathecal Catheter-Syringe Adaptor for Short-Term Intrathecal Analgesia with an Externalized Pump: A Case Report
Pain Physician, 03/19/10
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Polycythemia vera
Internal and Emergency Medicine, 03/19/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction
Journal of Pediatric Urology , 03/19/10
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/19/10
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/19/10
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Article Search
Sponsor
Sponsor